Advertisement

Ads Placeholder
Loading...

Glaukos Corporation

GKOS•NYSE
Healthcare
Medical - Devices
$112.77
$0.13(0.12%)
U.S. Market opens in 36h 1m

Glaukos Corporation (GKOS) Stock Overview

Explore Glaukos Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.5B
P/E Ratio-34.55
EPS (TTM)$-3.28
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$89.45
3 Months$58.37
1 Year Target$132.41

GKOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Glaukos Corporation (GKOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $132.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -34.55 and a market capitalization of 6.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.12%
5-Day Change
5.65%
1-Month Change
-4.23%
3-Month Change
1.85%
6-Month Change
29.01%
Year-to-Date (YTD) Change
1.85%
1-Year Change
29.62%
3-Year Change
127.77%
5-Year Change
40.23%
All-Time (Max) Change
261.21%

Contact Information

https://www.glaukos.com
949 367 9600
229 Avenida Fabricante, Aliso Viejo, CA, 92672

Company Facts

9,950 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions